Respondents predict that the highest rates will be reflected in all outpatient prescription drugs with an 11.4% increase, up ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...
The future of pain medicine is characterized by treatments and technologies — including virtual reality, AI, wearable tech ...
Cure” is a not an immutable term, the authors of a new study write, and its meaning depends on the context in which it is ...
Children with spinal muscular atrophy (SMA) experience benefits from receiving a disease-modifying gene therapy, but many ...
Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...
Merck and Johnson & Johnson have both acquired bispecific antibodies with applications in autoimmune and inflammatory conditions. Driving this growth will be the approvals of novel biologics, such as ...